WallStreetZenWallStreetZen

NASDAQ: ARCT
Arcturus Therapeutics Holdings Inc Stock Ownership - Who owns Arcturus Therapeutics Holdings?

Buy ARCT

Insider buying vs selling

Have Arcturus Therapeutics Holdings Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Pad ChivukulaChief Scientific Officer & COO2022-01-048,100$40.00
$324.00kSell
Pad ChivukulaChief Scientific Officer & COO2021-12-163,633$40.00
$145.33kSell
Pad ChivukulaChief Scientific Officer & COO2021-12-086,367$40.00
$254.68kSell
Pad ChivukulaChief Scientific Officer & COO2021-11-0110,000$44.41
$444.10kSell
Pad ChivukulaChief Scientific Officer & COO2021-10-0110,000$44.36
$443.60kSell
Pad ChivukulaChief Scientific Officer & COO2021-09-0110,000$55.86
$558.60kSell
Ultragenyx Pharmaceutical IncDirector2021-08-1175,000$45.83
$3.44MSell
Ultragenyx Pharmaceutical IncDirector2021-08-10725,000$55.44
$40.19MSell
Pad ChivukulaChief Scientific Officer & COO2021-08-0310,000$40.07
$400.70kSell

1 of 1

ARCT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

ARCT Shareholders

What type of owners hold Arcturus Therapeutics Holdings Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Federated Hermes Inc14.24%3,761,900$60.72MInstitution
State Street Corp12.18%3,217,957$51.94MInstitution
Ark Investment Management LLC9.02%2,383,840$38.48MInstitution
Blackrock Inc6.42%1,695,639$27.37MInstitution
Joseph E. Payne5.58%1,475,097$23.81MInsider
Sumitomo Mitsui Trust Holdings Inc5.31%1,402,078$22.63MInstitution
Nikko Asset Management Americas Inc5.31%1,402,078$22.63MInstitution
Ultragenyx Pharmaceutical Inc5.30%1,400,000$22.60MInsider
Vanguard Group Inc4.37%1,153,513$18.62MInstitution
Fmr LLC3.49%920,796$14.86MInstitution

1 of 3

ARCT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARCT81.20%14.59%Net Selling
COGT82.86%17.14%Net BuyingNet Buying
EWTX78.70%21.30%Net BuyingNet Buying
ABUS15.56%84.44%Net Selling
CNTA79.31%12.55%Net BuyingNet Selling

Arcturus Therapeutics Holdings Stock Ownership FAQ

Who owns Arcturus Therapeutics Holdings?

Arcturus Therapeutics Holdings (NASDAQ: ARCT) is owned by 81.20% institutional shareholders, 14.59% Arcturus Therapeutics Holdings insiders, and 4.20% retail investors. Joseph E. Payne is the largest individual Arcturus Therapeutics Holdings shareholder, owning 1.48M shares representing 5.58% of the company. Joseph E. Payne's Arcturus Therapeutics Holdings shares are currently valued at $23.81M.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.